{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:14:23Z","timestamp":1778580863302,"version":"3.51.4"},"reference-count":126,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.path.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T18:26:01Z","timestamp":1572287161000},"page":"1021-1044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas"],"prefix":"10.1016","volume":"12","author":[{"given":"Natalie","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1055-9965.EPI-05-0120","article-title":"Differences in survival by histologic type of pancreatic cancer","volume":"14","author":"Fesinmeyer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.path.2019.08.007_bib3","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/annonc\/mdt377","article-title":"Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531)","volume":"24","author":"Mocellin","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1152\/physrev.1998.78.4.1087","article-title":"The new biology of gastrointestinal hormones","volume":"78","author":"Rehfeld","year":"1998","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/17.5.303","article-title":"The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept","volume":"17","author":"Pearse","year":"1969","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"9","key":"10.1016\/j.path.2019.08.007_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s001090050261","article-title":"Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system","volume":"76","author":"Wiedenmann","year":"1998","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"8","key":"10.1016\/j.path.2019.08.007_bib7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/MPA.0b013e318292006a","article-title":"Giant insulinoma","volume":"42","author":"Callacondo","year":"2013","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4161\/isl.3.6.17866","article-title":"Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors","volume":"3","author":"Tomita","year":"2011","journal-title":"Islets"},{"issue":"9","key":"10.1016\/j.path.2019.08.007_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","article-title":"A\u00a0practical approach to the classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas","volume":"40","author":"Tang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"issue":"Sd 16","key":"10.1016\/j.path.2019.08.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2059481","article-title":"Characteristics and outcomes of 79 patients with an insulinoma: a nationwide retrospective study in Finland","volume":"2018","author":"Peltola","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"7 Suppl","key":"10.1016\/j.path.2019.08.007_bib12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jso.10142","article-title":"Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms","volume":"81","author":"Gumbs","year":"2002","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical,\u00a0genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.path.2019.08.007_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel-Lindau: how a rare disease illuminates cancer biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00428-013-1465-6","article-title":"Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease","volume":"463","author":"Gucer","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2019.08.007_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/gut.31.6.728","article-title":"Carcinoid tumour of the common bile duct-a novel complication of von Hippel-Lindau syndrome","volume":"31","author":"Fellows","year":"1990","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11605-009-1123-0","article-title":"Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases","volume":"14","author":"Relles","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.path.2019.08.007_bib19","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1210\/jc.2018-01074","article-title":"Hypercalcemia in glucagon cell hyperplasia and neoplasia (Mahvash syndrome): a new association","volume":"103","author":"Gild","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1210\/jc.2008-1300","article-title":"Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas","volume":"94","author":"Henopp","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.007_bib21","series-title":"WHO classification of tumours of the digestive system","first-page":"322","article-title":"Neuroendocrine neoplasms of the pancreas","author":"Klimstra","year":"2010"},{"issue":"12","key":"10.1016\/j.path.2019.08.007_bib22","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/PAS.0b013e318263207c","article-title":"Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system","volume":"36","author":"Tang","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jcp.43.7.597","article-title":"Does delay in fixation affect the number of mitotic figures in processed tissue?","volume":"43","author":"Cross","year":"1990","journal-title":"J\u00a0Clin Pathol"},{"issue":"12","key":"10.1016\/j.path.2019.08.007_bib24","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1097\/PAS.0b013e318263209d","article-title":"Clinicopathologic study of 62 acinar cell carcinomas of the pancreas","volume":"36","author":"Casnedi","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0000000000000341","article-title":"Mitotic count by phosphohistone h3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas","volume":"39","author":"Voss","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.semdp.2013.06.005","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues","volume":"30","author":"Yang","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.path.2019.08.007_bib27","series-title":"WHO classification of tumours of the digestive system","first-page":"13","article-title":"Nomenclature and classification of neuroendocrine neoplasms of the digestive system","author":"Rindi","year":"2010"},{"key":"10.1016\/j.path.2019.08.007_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/modpathol.2016.225","article-title":"Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors","volume":"30","author":"Matsukuma","year":"2017","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/PAS.0b013e31821a0696","article-title":"Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver","volume":"35","author":"Yang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.007_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/modpathol.2008.177","article-title":"Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors","volume":"22","author":"Couvelard","year":"2009","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.08.007_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1634\/theoncologist.2015-0476","article-title":"Gastroentero pancreatic well-differentiated grade 3 neuroendocrine tumors: review and position statement","volume":"21","author":"Coriat","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.path.2019.08.007_bib32","series-title":"WHO classification of tumours of endocrine organs","first-page":"209","article-title":"WHO classification of neoplasms of the neuroendocrine pancreas","author":"Klopperl","year":"2017"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-15-0119","article-title":"Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms","volume":"22","author":"Heetfeld","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncy.21982","article-title":"Well\u00a0differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: a morphologic study","volume":"126","author":"Sigel","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/j.path.2019.08.007_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12020-017-1273-x","article-title":"Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms","volume":"58","author":"Leoncini","year":"2017","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2019.08.007_bib39","series-title":"AJCC cancer staging manual","year":"2017"},{"issue":"8","key":"10.1016\/j.path.2019.08.007_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00000478-198408000-00004","article-title":"Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms","volume":"8","author":"Lloyd","year":"1984","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.semdp.2014.08.008","article-title":"Pancreatic neuroendocrine tumors: pathologic and molecular characteristics","volume":"31","author":"Shi","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.path.2019.08.007_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.08.007_bib43","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","article-title":"INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity","volume":"41","author":"Rooper","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41379-018-0122-7","article-title":"Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections","volume":"32","author":"Mukhopadhyay","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","volume":"51","author":"Tanigawa","year":"2018","journal-title":"Med Mol Morphol"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/PAS.0000000000001037","article-title":"INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors","volume":"42","author":"Rooper","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/cup.13079","article-title":"Insulinoma-associated 1: a novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)","volume":"45","author":"Rush","year":"2018","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0b013e31824aba59","article-title":"PDX-1, CDX-2, TTF-1, and CK7","volume":"36","author":"Chan","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAS.0b013e31818d7d8b","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors","volume":"33","author":"Srivastava","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0000000000000876","article-title":"Immunohistochemical characterization of the origins of metastatic well-differentiated neuroendocrine tumors to the liver","volume":"41","author":"Yang","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40364-018-0129-8","article-title":"NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors","volume":"6","author":"Yang","year":"2018","journal-title":"Biomark Res"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/modpathol.2012.34","article-title":"Value of islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin","volume":"25","author":"Mertens","year":"2012","journal-title":"Mod Pathol"},{"issue":"18","key":"10.1016\/j.path.2019.08.007_bib54","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000448431","article-title":"Professional practices and diagnostic issues in neuroendocrine tumour pathology: results of a prospective one-year survey among French pathologists (the PRONET Study)","volume":"105","author":"Scoazec","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib56","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib57","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00428-005-0147-4","article-title":"Multihormonality and entrapment of islets in pancreatic endocrine tumors","volume":"448","author":"Kapran","year":"2006","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-0985-6","article-title":"Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis","volume":"458","author":"Konukiewitz","year":"2011","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/ERC-07-0157","article-title":"Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity","volume":"15","author":"Garbrecht","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.path.2019.08.007_bib60","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.humpath.2011.09.014","article-title":"Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement","volume":"43","author":"McCall","year":"2012","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.sla.0000167862.52309.7d","article-title":"Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type","volume":"242","author":"Borch","year":"2005","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.path.2019.08.007_bib62","first-page":"1378","article-title":"Pernicious anemia and gastric carcinoid tumor: case report and review","volume":"92","author":"Sculco","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.path.2019.08.007_bib63","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/1097-0142(19940415)73:8<2053::AID-CNCR2820730807>3.0.CO;2-0","article-title":"Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients","volume":"73","author":"Thomas","year":"1994","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-12-0836","article-title":"Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study","volume":"168","author":"Thomas","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.path.2019.08.007_bib65","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10620-014-3410-1","article-title":"Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience","volume":"60","author":"Chen","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"46","key":"10.1016\/j.path.2019.08.007_bib66","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.3748\/wjg.v19.i46.8687","article-title":"Metastatic type 1 gastric carcinoid: a real threat or just a myth?","volume":"19","author":"Grozinsky-Glasberg","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.path.2019.08.007_bib67","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1245\/s10434-009-0687-y","article-title":"Defining surgical indications for type I gastric carcinoid tumor","volume":"16","author":"Gladdy","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib68","first-page":"338","article-title":"Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion","volume":"90","author":"Gilligan","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1634\/theoncologist.2013-0369","article-title":"Zollinger-Ellison syndrome: classical considerations and current controversies","volume":"19","author":"Epelboym","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.sla.0000234802.44320.a5","article-title":"Surgery increases survival in patients with gastrinoma","volume":"244","author":"Norton","year":"2006","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0344-0338(11)80891-5","article-title":"Endocrine tumours of the stomach","volume":"191","author":"Bordi","year":"1995","journal-title":"Pathol Res Pract"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib72","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1572-0241.2007.01185.x","article-title":"A\u00a0three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress","volume":"102","author":"Modlin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.path.2019.08.007_bib73","first-page":"292","article-title":"Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis","volume":"3","author":"Tsikitis","year":"2012","journal-title":"J\u00a0Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archsurg.2009.80","article-title":"Neuroendocrine tumors of the ampulla of vater: biological behavior and surgical management","volume":"144","author":"Carter","year":"2009","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib76","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.0.CO;2-E","article-title":"Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases","volume":"79","author":"Burke","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.path.2019.08.007_bib77","first-page":"317","article-title":"Surgical management of gastrointestinal carcinoid tumors","volume":"28","author":"Loftus","year":"1995","journal-title":"Adv Surg"},{"issue":"30","key":"10.1016\/j.path.2019.08.007_bib78","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.2013.51.1477","article-title":"Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors","volume":"31","author":"Kim","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib79","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000197899","article-title":"Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut","volume":"89","author":"Strosberg","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.20179","article-title":"Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract","volume":"89","author":"Rorstad","year":"2005","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib81","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000478742","article-title":"Surgical management of patients with neuroendocrine neoplasms of the appendix: appendectomy or more","volume":"106","author":"Pawa","year":"2018","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.21764","article-title":"Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival","volume":"103","author":"Groth","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jso.21888","article-title":"Carcinoid tumors of the appendix: a population-based study","volume":"104","author":"Mullen","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000493894","article-title":"Unmet needs in appendiceal neuroendocrine neoplasms","volume":"108","author":"Toumpanakis","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib85","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/94.1.27","article-title":"Goblet cell carcinoids and related tumors of the vermiform appendix","volume":"94","author":"Burke","year":"1990","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.08.007_bib86","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0b013e31817f1816","article-title":"Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix","volume":"32","author":"Tang","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib87","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/PAS.0000000000001056","article-title":"Histologic and outcome study supports reclassifying appendiceal goblet cell carcinoids as goblet cell adenocarcinomas, and grading and staging similarly to colonic adenocarcinomas","volume":"42","author":"Yozu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.007_bib88","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.humpath.2015.08.005","article-title":"Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix","volume":"46","author":"Lee","year":"2015","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.08.007_bib89","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/1097-0142(19920515)69:10<2400::AID-CNCR2820691003>3.0.CO;2-Z","article-title":"Incidence and mortality of carcinoids of the colon. Data from the connecticut tumor registry","volume":"69","author":"Ballantyne","year":"1992","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib90","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000335594","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms","volume":"95","author":"Caplin","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib91","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1245\/s10434-006-9311-6","article-title":"Carcinoid of the Rectum Risk Stratification (CaRRs): a strategy for preoperative outcome assessment","volume":"14","author":"Fahy","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib92","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.surg.2008.05.005","article-title":"A\u00a0proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients","volume":"144","author":"Landry","year":"2008","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.path.2019.08.007_bib93","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1055\/s-0033-1344794","article-title":"Updating the management of patients with rectal neuroendocrine tumors","volume":"45","author":"de Mestier","year":"2013","journal-title":"Endoscopy"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib94","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0038-1642054","article-title":"Small bowel and colorectal carcinoids","volume":"31","author":"Byrne","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib95","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/00365521.2016.1261938","article-title":"Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study","volume":"52","author":"Lee","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib96","first-page":"8604","article-title":"Analysis of the clinicopathological features and prognostic factors of primary hepatic neuroendocrine tumors","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib97","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12253-014-9808-4","article-title":"neuroendocrine tumors of extrahepatic biliary tract","volume":"20","author":"Michalopoulos","year":"2014","journal-title":"Pathol Oncol Res"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib98","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pan.2015.08.007","article-title":"Pathology, genetics and precursors of human and experimental pancreatic neoplasms: an update","volume":"15","author":"Esposito","year":"2015","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors","volume":"95","author":"Falconi","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.surg.2012.08.038","article-title":"Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management","volume":"152","author":"Lee","year":"2012","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib101","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF01297144","article-title":"clinical pathology of endocrine tumors of the pancreas. analysis of autopsy cases","volume":"36","author":"Kimura","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00428-006-0154-0","article-title":"Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas","volume":"448","author":"Volante","year":"2006","journal-title":"Virchows Arch"},{"issue":"9","key":"10.1016\/j.path.2019.08.007_bib103","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.pas.0000164370.81132.25","article-title":"Pleomorphic pancreatic endocrine neoplasms: a variant commonly confused with adenocarcinoma","volume":"29","author":"Zee","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11605-009-1115-0","article-title":"Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients","volume":"14","author":"Franko","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.path.2019.08.007_bib106","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PAS.0000000000000383","article-title":"Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors","volume":"39","author":"Kim","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib107","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib108","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MPA.0000000000000762","article-title":"Everolimus in pancreatic neuroendocrine carcinomas G3","volume":"46","author":"Panzuto","year":"2017","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.path.2019.08.007_bib109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ctrv.2008.10.007","article-title":"Clinical and therapeutic aspects of extrapulmonary small cell carcinoma","volume":"35","author":"Walenkamp","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.path.2019.08.007_bib110","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.ejca.2012.12.022","article-title":"Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry","volume":"49","author":"Korse","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000442207","article-title":"Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010","volume":"104","author":"Cetinkaya","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib112","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00384-006-0145-2","article-title":"Rare tumors of the colon and rectum: a national review","volume":"22","author":"Kang","year":"2007","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib113","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/cncr.31124","article-title":"Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases","volume":"124","author":"Dasari","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2016.150","article-title":"In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components","volume":"30","author":"Woischke","year":"2017","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.08.007_bib115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4251\/wjgo.v3.i10.144","article-title":"TTF-1 positive small cell cancers: don\u2019t think they\u2019re always primary pulmonary!","volume":"3","author":"Verset","year":"2011","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.path.2019.08.007_bib116","series-title":"WHO classification of tumours of endocrine organs","first-page":"238","article-title":"Mixed neuroendocrine-non-neuroendocrine neoplasms","author":"Ohike","year":"2017"},{"issue":"4","key":"10.1016\/j.path.2019.08.007_bib117","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3748\/wjg.v9.i4.858","article-title":"Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases","volume":"9","author":"Yao","year":"2003","journal-title":"World J Gastroenterol"},{"issue":"22","key":"10.1016\/j.path.2019.08.007_bib118","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.35.1817","article-title":"Prognostic validity of a Novel American Joint Committee on Cancer staging classification for pancreatic neuroendocrine tumors","volume":"29","author":"Strosberg","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2019.08.007_bib119","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1634\/theoncologist.2018-0382","article-title":"High-grade gastrointestinal neuroendocrine carcinoma management and outcomes: a national cancer database study","volume":"24","author":"Alese","year":"2019","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.path.2019.08.007_bib120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/2159-8290.CD-15-1192","article-title":"BRAFV600E mutations in high-grade colorectal neuroendocrine tumors may predict responsiveness to BRAF-MEK combination therapy","volume":"6","author":"Klempner","year":"2016","journal-title":"Cancer Discov"},{"issue":"6021","key":"10.1016\/j.path.2019.08.007_bib121","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"7643","key":"10.1016\/j.path.2019.08.007_bib122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.path.2019.08.007_bib123","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.04.002","article-title":"Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: a systematic review","volume":"56","author":"Girardi","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10.1016\/j.path.2019.08.007_bib124","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.humpath.2015.08.006","article-title":"Molecular characteristics of colorectal neuroendocrine carcinoma; Similarities with adenocarcinoma rather than neuroendocrine tumor","volume":"46","author":"Takizawa","year":"2015","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.007_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/ERC-14-0410","article-title":"Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity","volume":"22","author":"Sahnane","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.08.007_bib126","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.24834","article-title":"Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma","volume":"117","author":"Idrees","year":"2018","journal-title":"J\u00a0Surg Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:31Z","timestamp":1761748831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1875918119300637"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.08.007","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}